Diagnostic Solutions for Improved Health

Zora Biosciences is a diagnostics company. We identify markers of disease and develop them into robust high-throughput, value-added clinical methods.

Read more about Zora

CERT – Coronary Event Risk Test

CERT is a blood based diagnostic test that identifies patients who are at risk of heart attack or cardiovascular death. CERT helps to find high-risk patients even if their other clinical parameters such as LDL-C might suggest that they are not at an elevated risk. In Finland, CERT is known as Hertta.

Learn more about Hertta

Plasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndrome

Gencer et al. 2020 European Journal of Preventive Cardiology. Published online Dec 2020

Read more  

Zora publications

Please check our latest publications including our research on coronary event risk. The publications can be found from News - Publications.